Literature DB >> 8626417

Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes.

M D Hines1, B L Allen-Hoffmann.   

Abstract

Keratinocyte growth factor (KGF) exhibits paracrine action on numerous epithelia, including skin. We have found that cultures of normal human keratinocytes must attain confluence before KGF promotes an increase in cell number relative to untreated controls. In postconfluent cultures, treatment with KGF promoted tight packing of keratinocytes with a small basal cell morphology. Based on these observations, we hypothesized that KGF increased cell number in postconfluent cultures by affecting the ability of normal keratinocytes to undergo terminal differentiation and/or programmed cell death. In support of this hypothesis, keratinocytes treated with KGF produced fewer cross-linked envelopes and exhibited reduced membrane-associated transglutaminase activity relative to cells treated with epidermal growth factor or untreated controls. We also found that nucleosomal fragmentation was reduced in postconfluent cultures of KGF-treated keratinocytes. Furthermore, KGF-treated keratinocytes were more resistant to suspension-induced nucleosomal fragmentation than control or epidermal growth factor-treated cultures. Therefore, it appears that KGF modulates aspects of keratinocyte terminal differentiation which share features with programmed cell death. We propose that stromally-derived KGF may act as a paracrine survival factor in skin and perhaps other renewal tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626417     DOI: 10.1074/jbc.271.11.6245

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.

Authors:  T Wrone-Smith; R S Mitra; C B Thompson; R Jasty; V P Castle; B J Nickoloff
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

2.  KGF Promotes Paracrine Activation of the SCF/c-KIT Axis from Human Keratinocytes to Melanoma Cells.

Authors:  Francesca Belleudi; Giorgia Cardinali; Daniela Kovacs; Mauro Picardo; Maria Rosaria Torrisi
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

3.  Altered expression of keratinocyte growth factor and its receptor in psoriasis.

Authors:  P W Finch; F Murphy; I Cardinale; J G Krueger
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytes.

Authors:  Raduwan Dackour; Timothy Carter; Bettie M Steinberg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Mar-Apr       Impact factor: 2.416

5.  Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues.

Authors:  A Friedl; Z Chang; A Tierney; A C Rapraeger
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

6.  Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.

Authors:  Tomomi Yamamoto-Fukuda; Mariko Terakado; Yoshitaka Hishikawa; Takehiko Koji; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

7.  The receptor tyrosine kinase FGFR2b/KGFR controls early differentiation of human keratinocytes.

Authors:  Francesca Belleudi; Valeria Purpura; Maria Rosaria Torrisi
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

8.  Simultaneous Targeting Tumor Cells and Cancer-Associated Fibroblasts with a Paclitaxel-Hyaluronan Bioconjugate: In Vitro Evaluation in Non-Melanoma Skin Cancer.

Authors:  Barbara Bellei; Silvia Caputo; Emilia Migliano; Gianluca Lopez; Valeria Marcaccini; Carlo Cota; Mauro Picardo
Journal:  Biomedicines       Date:  2021-05-24

9.  Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cells.

Authors:  Sabrina Rotolo; Simona Ceccarelli; Ferdinando Romano; Luigi Frati; Cinzia Marchese; Antonio Angeloni
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

10.  Role of FGFR2b expression and signaling in keratinocyte differentiation: sequential involvement of PKCδ and PKCα.

Authors:  Benedetta Rosato; Danilo Ranieri; Monica Nanni; Maria Rosaria Torrisi; Francesca Belleudi
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.